Robert R. Redfield, former director of the Centers for Disease Control and Prevention, is cofounder and associate director of ...

It is the first test the FDA has cleared for use in symptomatic adults aged 40 and over, according to C2N Diagnostics.

According to the findings, these changes occurred at least seven years before amyloid plaques became visible on scans. The ...

Genetic risk beyond APOE was linked to cognition, hippocampal volume, amyloid and tau across several ancestry groups.

New research points to certain immune cells in our lymph nodes that play a key role in causing the brain damage seen with ...

Will getting a blood test for amyloid levels eventually form part of routine primary care health checks, or are we putting ...

Our understanding of the causes of Alzheimer’s disease is evolving. Recent discoveries have revealed the important role of ...

An NHS trust in the UK has become the first site in Europe to offer Roche's experimental drug trontinemab to patients ...

The trial will give the drug Trontinemab to those at high risk of Alzheimer’s to see if the disease can be delayed or ...

A study published in the renowned science journal Science Advances has astonished doctors and scientists worldwide. According ...

A protein thought to play a critical role in the progression of Alzheimer’s disease may not originate where scientists ...